Stay updated with breaking news from Looking Statements. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
End-of-treatment data from two Phase 2a combination clinical trials with imdusiran to be presented at the EASL Congress in June 2024 Preliminary data from the single-dose portion of the AB-101-001...
WARMINSTER, Pa., May 02, 2024 -- Arbutus Biopharma Corporation , a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional cure for people with...
First Quarter Report to Shareholders 12 weeks ended March 23, 2024 2024 First Quarter Report to...
CONTACT: Dan Lombardo Vice President of Investor Relations 630-570-0605dan.lombardo@inventrustproperties.com ...
Planet 13 Announces Release Date of First Quarter 2024 Financial Results ...